Former Titan Spine executive joins Vivex Biologics

Regenerative medicine company Vivex Biologics appointed Chad Kolean as CFO Feb. 12.

Advertisement

Mr. Kolean joins from spinal implant developer Titan Spine, which was acquired by Medtronic last year. 

Previously he served as CFO and treasurer for Cellectar Biosciences and Pioneer Surgical Technology, before it merged with RTI Surgical.

Early in his career, Mr. Kolean held several leadership positions within the healthcare and finance sectors, including Tomotherapy, Metavante Corp. and Arthur Andersen.

More articles on devices:
Spinal fusion will be performed for ‘decades to come’: Key thoughts from 4 surgeons
Challenges facing private practices in spine, and strategies to tackle them
10 numbers that show how big Johnson & Johnson is in spine, orthopedics

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.